Exelixis, Inc. Profile Avatar - Palmy Investing

Exelixis, Inc.

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients…
Biotechnology
US, Alameda [HQ]
End of EXEL's Analysis
CIK: 939767 CUSIP: 30161Q104 ISIN: US30161Q1040 LEI: - UEI: -
Secondary Listings
EXEL has no secondary listings inside our databases.